Evaluation of the performance of SARS-­CoV­-2 antibody assays for a longitudinal population­based study of COVID-­19 spread in St. Petersburg, Russia

Institute for Interdisciplinary Health Research (IIHR)
Publication URL:
https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.27126
Author(s):

Anton Barchuk, Daniil Shirokov, Mariia Sergeeva, Rustam Tursun­zade, Olga Dudkina, Varvara Tychkova, Lubov Barabanova, Dmitriy Skougarevskiy, Daria Danilenko

Тип издания:
Журнал
Year of publication:

This study summarizes an evaluation of antibody tests used in a serological study of SARS-­CoV­-2 in Saint Petersburg, Russia. Researches validated three different antibody assays: chemiluminescent microparticle immunoassay (CMIA) Abbott Architect SARS-­CoV­-2 immunoglobulin G (IgG), enzyme­ linked immunosorbent assay (ELISA) CoronaPass total antibodies test, and ELISA SARS­-CoV-­2-­IgG-­EIA-­BEST.